Terkko Navigator / Vox Sanguinis

Washed red cells: theory and practice

Maternity iron, anaemia and blood management in South Australia: a practice‐based evidence for clinical practice improvement

RAGE interacts with the necroptotic protein RIPK3 and mediates transfusion‐induced danger signal release

Introduction of principles of blood management to healthy donor bone marrow harvesting

Preference for whole blood versus plasma donation among university students

Prevalence and risks of hepatitis E virus infection in blood donors from the Western Cape, South Africa

Overcoming the challenges of interpreting complex and uncommon RH alleles from whole genomes

Clinical use of Convalescent Plasma in the COVID‐19 pandemic; a transfusion‐focussed gap analysis with recommendations for future research priorities

Blood donation and the global COVID‐19 pandemic: areas for social science research

Guidance for the Procurement of COVID‐19 Convalescent Plasma: Differences between High and Low‐Middle Income Countries

Vox Sanguinis International Forum on Hospital Transfusion Services’ Response to COVID‐19

Early experience with convalescent plasma as immunotherapy for COVID‐19 in China: Knowns and unknowns

Report on the 19th International Society of Blood Transfusion Platelet Immunology Workshop 2018

The use of the GeeniusTM HIV‐1/2 Rapid confirmatory test for the enrolment of patients and blood donors in the WHO Universal Test and Treat Strategy in Cameroon, Africa

Use of COVID‐19 convalescent plasma in low‐ and middle‐income countries: a call for ethical principles and the assurance of quality and safety

Prevalence of red‐blood‐cell and non‐red‐blood‐cell‐targeted autoantibodies in alloimmunized postpartum women

Changes to hepatic tissue oxygenation, abdominal perfusion and its association with enteral feeding with liberal transfusion threshold in anaemic preterm infants: A prospective cohort study.

Vox Sanguinis International Forum on Transfusion Services about Response to COVID‐19

Vox Sanguinis International Forum on the selection and preparation of blood components for intrauterine transfusion: Summary

Vox Sanguinis International forum on the selection and preparation of blood components for intrauterine transfusion

Novel hybrid genes and a splice site mutation encoding the Sta antigen among Japanese blood donors

Vox Sanguinis International Forum on Donor Incentives: Summary

Vox Sanguinis International Forum on Donor Incentives

Soluble mediators in packed red‐blood‐cells augment lipopolysaccharide‐induced monocyte interleukin‐1β production

Vox Sanguinis International Forum on Transfusion Services about Response to COVID‐19

Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light

A novel cancer immunotherapy utilizing autologous tumour tissue

Colloid osmotic pressure of contemporary and novel transfusion products

Lipid ratios as a marker for red blood cell storage quality and as a possible explanation for donor gender differences in storage quality

Gender‐neutral donor deferral policies: experience in Argentina implementing individual risk‐assessment policies

Perceptions on consumer information in transfusion. A qualitative study of consumers and prescribers

In vitro phagocytosis of liquid‐stored red blood cells requires serum and can be inhibited with fucoidan and dextran sulphate

Impact of COVID‐19 on blood centres in Zhejiang province China

Impact of long‐term storage of plasma and cell‐free DNA on measured DNA quantity and fetal fraction

Reducing the red blood cell transfusion threshold from 8·0 g/dl to 7·0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcome

Operational protocol for donation of anti‐COVID‐19 convalescent plasma in Italy

Points to consider in the preparation and transfusion of COVID‐19 convalescent plasma

Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment

Pro‐inflammatory effects after platelet transfusion: a review

Coronavirus‐19 Disease (COVID‐19) and Decrease in Blood Donation: Experience of Iranian Blood Transfusion Organization (IBTO)

Blood transfusions in mass casualty events: recent trends

Red‐blood‐cell alloimmunization and prophylactic antigen matching for transfusion in patients with warm autoantibodies

Pivotal Role of Convalescent Plasma in Managing Emerging Infectious Diseases

The impact of the SARS‐CoV‐2 outbreak on the safety and availability of blood transfusions in Italy

Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how

Post‐donation COVID‐19 identification in blood donors

Potential impact of a delayed ADAMTS13 result in the treatment of thrombotic microangiopathy: an economic analysis

A small allelic variant in donor class I MHC is sufficient to induce alloantibodies following transfusion of standard or pathogen‐reduced platelets in mice

Characterization of GYP*Mur and novel GYP*Bun‐like hybrids in Thai blood donors reveals a qualitatively altered s antigen

Electronic charting of transfusion medicine consults: implementation, challenges and opportunities